BMS-833923,
Bristol-Myers Squibb 833923,
BMS-833923,
1059734-66-5,
BMS 833923,
XL139,
BMS833923,
N-(2-Methyl-5-((methylamino)methyl)phenyl)-4-((4-phenylquinazolin-2-yl)amino)benzamide,
XL 139,
XL-139,
UNII-41J7ZJ239R,
41J7ZJ239R,
N-(2-methyl-5-((methylamino)methyl)phenyl)-4-(4-phenylquinazolin-2-ylamino)benzamide,
C30H27N5O,
Benzamide, N-[2-methyl-5-[(methylamino)methyl]phenyl]-4-[(4-phenyl-2-quinazolinyl)amino]-,
N-[2-methyl-5-(methylaminomethyl)phenyl]-4-[(4-phenylquinazolin-2-yl)amino]benzamide,
BMS-833923 free base anhydrous,
XL139 mesylate,
GTPL8202,
SCHEMBL4138073,
CHEMBL3545403,
EX-A789,
HMS3653O09,
AOB87352,
BCP07837,
BCP23569,
2281AH,
MFCD25976660,
s7138,
ZINC96170449,
AKOS026750412,
ACN-053033,
BMS-833923XL-139,
CS-1464,
SB16486,
NCGC00386301-06,
4CA-0306,
AK474035,
BC600392,
HY-13809,
QC-10011,
BMS-833923 (XL139),
AB0097984,
BMS-833923 (XL-139),
FT-0739836,
SW219814-1,
W-6085,
J-690018,
Poziotinib,
D03DUY,
A3258,
A13204,
N-(2-methyl-5-((methylamino)methyl)phenyl)-4-((4-phenylquinazolin-2-yl)amino)benzamide.,